We are Sorry, This Page doesn't Exist
Here Comes Obesity Drug Competition: Amgen Shares Soar On "Very Encouraging" Clinical Trial Update
Here Comes Obesity Drug Competition: Amgen Shares Soar On "Very Encouraging" Clinical Trial Update Amgen's shares soared in premarket trading in New York following the drug maker's announcement of "very encouraging" clinical trial results f.....»»
AstraZeneca"s Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Shows
AstraZeneca's updated data from TOPAZ-1 Phase 3 trial of Imfinzi (durvalumab) in advanced biliary tract cancer patients. Unveiling long-term survival benefits and significant overall survival improvement. read more.....»»
Small-Cap Cancer Drug Developer Agenus" Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom
The latest Phase 1 trial results of Agenus' botensilimab and balstilimab (BOT/BAL) combination therapy for metastatic CRC showcase promising clinical activity. Latest Ratings for A.....»»
AstraZeneca to present update on ph3 trial of LYNPARZA in early breast cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Myovant"s stock falls after FDA puts partial clinical hold on trial for contraceptive candidate
Shares of Myovant Sciences Ltd. were down 5.7% in premarket trading on Wednesday after the company told investors that the Food and Drug Administration had placed a partial clinical hold on a study assessing an experimental birth c.....»»
BioLine RX rockets on heavy volume after "strikingly positive" trial data on cancer treatment
Shares of BioLine RX Ltd. rocketed 60% toward a 2-year high in very active trading Tuesday, enough to pace all of the premarket gainers, after the biopharmaceutical company announced positive results from a Phase 3 trial of its treatment for multi.....»»
Reviva"s stock jumps after experimental schizophrenia drug meets endpoint in Phase 2 clinical trial
Shares of Reviva Pharmaceuticals Holdings Inc. soared 76.6% in trading on Monday after the company said its experimental treatment .....»»
Novartis" Canakinumab Fails To Improve Survival In Late-Stage Lung Cancer Trial
Novartis AG (NYSE: NVS) reported data from the read more.....»»
GSK to refocus study of experimental COVID-19 antibody treatment on patients 70 and older
Shares of GlaxoSmithKline were down 0.2% in trading on Thursday after the drug maker said its experimental monoclonal antibody treatment did not meet the primary endpoint in a mid-stage trial evaluating its use in hospitalized COVID-19 patients of all a.....»»
AstraZeneca exec tells Congress it could have 50 million doses of its COVID-19 vaccine ready in April
Shares of AstraZeneca were up 0.1% in after-hours trading on Tuesday after a company executive testified before Congress that the drug maker expec.....»»
Heat Biologics stock more than doubles after "positive" trial data of its lung cancer treatment
Shares of Heat Biologics Inc. more than doubled in very active trading Tuesday, after the biopharmaceutical company focused on modulating the immune system reported "positive" in.....»»
Immunovant plunges nearly 50% after pausing a trial for its eye drug after unexpected cholesterol finding
Shares of Immunovant lost nearly half their value on Tuesday after the company announced a voluntary pause of trials of its IMVT-1401 eye drug. A researcher works on a vaccin against the new coronavirus COVID-19 at .....»»
Myovant shares soar 27% on news of Pfizer prostate cancer drug collaboration worth up to $4.2 billion
Shares of Myovant.....»»
UPDATE: Myovant shares soar 20% premarket on news of Pfizer cancer drug deal worth up to $4.2 billion
Shares of Myovant Sciences soared 20% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant wi.....»»
Myovant shares soar 16% premarket on news of Pfizer cancer drug deal worth up to $4.2 billion
Shares of Myovant Sciences soared 16% in premarket trade Monday, after its parent Sumitovant Biopharma said .....»»
Akebia"s shares jump on late-stage clinical trial results for kidney disease drug
Shares of Akebia Therapeutics Inc. gained 30% in premarket trading on.....»»
Axsome Shares Jump 25% on Alzheimer’s Study Results
Clinical trial of AX-05 showed drug reduces patient agitationRelated Stocks: AXSM, LLY, RHHBY, ACIU, MOR, ESALY, BIIB,.....»»
Saint Luke"s cardiologist leads trial to see if diabetes drug can prevent serious Covid-19 complications
Saint Luke's Mid America Heart Institute and drug company AstraZeneca PLC are conducting a clinical trial to see if a drug now used to treat diabetes could help prevent deadly complications in Covid-19 patients. The DARE-19 trial involves dapagliflozin,.....»»
Why BioSig Technology"s Stock Is Trading Higher Friday
BioSig Technology (NASDAQ: BSGM) shares are trading higher on Friday after the company's subsidiary VirtalClear submitted an investigational new drug application to the FDA for a Phase 2 clinical trial of Merimepodib. read more.....»»
Gilead stock tumbles after Stat report on weak data in remdesivir trial in China
Shares of Gilead Sciences Inc. were down 5.3% in trading on Thursday after a Stat News report said a draft of the clinical trial results for remdesivir, an experimental drug being tested as a treatment for COVID-19, showed that the drug did not spe.....»»